4-102536261-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003998.4(NFKB1):c.160-1597T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.587 in 151,890 control chromosomes in the GnomAD database, including 26,389 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.59   (  26389   hom.,  cov: 32) 
Consequence
 NFKB1
NM_003998.4 intron
NM_003998.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.0230  
Publications
34 publications found 
Genes affected
 NFKB1  (HGNC:7794):  (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020] 
NFKB1 Gene-Disease associations (from GenCC):
- immunodeficiency, common variable, 12Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
 - common variable immunodeficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.674  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.588  AC: 89184AN: 151772Hom.:  26378  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
89184
AN: 
151772
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.587  AC: 89218AN: 151890Hom.:  26389  Cov.: 32 AF XY:  0.585  AC XY: 43415AN XY: 74240 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
89218
AN: 
151890
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
43415
AN XY: 
74240
show subpopulations 
African (AFR) 
 AF: 
AC: 
24144
AN: 
41372
American (AMR) 
 AF: 
AC: 
7918
AN: 
15246
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2295
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
2713
AN: 
5168
South Asian (SAS) 
 AF: 
AC: 
3342
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
5765
AN: 
10544
Middle Eastern (MID) 
 AF: 
AC: 
208
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
40968
AN: 
67956
Other (OTH) 
 AF: 
AC: 
1289
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1886 
 3773 
 5659 
 7546 
 9432 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 758 
 1516 
 2274 
 3032 
 3790 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2024
AN: 
3474
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.